GRI Bio Inc. (GRI) Stock Analysis

GRI Bio Inc. (GRI) is a publicly traded company in the HEALTHCARE sector. It trades at $2.03, carries a market capitalization of $3.67M, a price-to-earnings ratio of 0.05. This page summarizes the public market data, fundamentals, and frequently asked questions for GRI, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.03
• Market Cap: $3.67M
• P/E Ratio: 0.05
• EPS: $38.89
• 52-Week High: $80.36
• 52-Week Low: $1.97

Market Sentiment

GRI Bio Inc. currently has a Neutral sentiment score of 0.08.

About GRI Bio Inc.

None

GNG Research Analysis

GNG Research scores GRI Bio Inc. (GRI) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GRI.

Frequently Asked Questions

Does GRI pay dividends?

GRI Bio Inc. (GRI) does not currently pay a regular dividend.

What is GRI's P/E ratio?

GRI Bio Inc. has a price-to-earnings (P/E) ratio of 0.05.

What is GRI's market cap?

GRI Bio Inc. (GRI) has a market capitalization of $3.67M with a current stock price of $2.03.